TMCnet News
Crossix Launches DIFA HCP™ to Enable Enhanced Measurement Across the Full HCP Digital Media LandscapeCrossix announced today that it has expanded its DIFA™ measurement platform to encompass healthcare professional (HCP) digital campaigns in addition to direct-to-consumer, site, and search campaigns. Healthcare brands and agencies can now measure and validate that their display, mobile, and video campaigns are reaching their target HCPs and driving impact. "Crossix's DIFA platform has played an instrumental role in helping us improve optimization of our clients' consumer digital campaigns for maximum return," said Jacob Lustig, Vice President, Media Platforms and Attribution at Klick Health. "We can now evaluate non-endemic programmatic media programs and reach HCPs across multiple devices-even when HCP-level reporting is not provided by the publisher-while adhering to our guiding principles of media accountability, media impact, and ROI." Leading healthcare marketers have depended on DIFA for over 4 years, leveraging its data to optimize over 100 campaigns and more than 25 billion media impressions. Previously, marketers could only rely on self-reported exposure data from HCP publishers. With the extension of programmatic buying to HCPs, clients can now collect exposure data for all partners on the media plans. Powered by the Crossix HCP Match Graph, DIFA HCP is designed to complement and enhance existing HCP analyses, offering detailed insights across digital channels for the full exposed audience. Additionally, marketers can also connect HCP data with DIFA consumer media analytics for a more complete picture of their overall digital marketing initiatives. DIFA HCP provides brands and agencies with non-biased verification of how their HCP campains are performing across the full digital landscape. DIFA HCP verifies whether each media source within a campaign is reaching professionals on an advertiser's target list and evaluates the overall ROI for each campaign, based on connecting HCP exposure to their patients' treatment behavior. "Crossix is all about developing solutions that push the industry forward, and with DIFA HCP, we are doing just that," said Dan Stein, Senior Vice President of Analytics Services & Product Strategy at Crossix. "Used as a supplement to existing publisher analyses, DIFA HCP offers marketers independent, third-party verification that their campaigns are reaching the intended target and driving meaningful impact across traditional and emerging media options." While other companies measure a portion of the many professional devices an HCP uses, Crossix captures more types of data to deliver a comprehensive view of the HCPs reached, as well as the profile and actions taken by those HCPs' patients. In addition, DIFA HCP:
For more information, please visit www.crossix.com/DIFA-HCP. About Crossix Solutions Crossix empowers healthcare companies and companies that care about health to plan, measure and optimize their marketing and communication initiatives. Fueled by its Distributed Data Network (DDN) technology and the industry's most comprehensive set of health and non-health data, which encompasses more than 250 million U.S. consumers, Crossix analytics inform strategic decisions, maximize business results, and drive improved patient outcomes. Crossix connects Rx, OTC, CPG, clinical, medical claims, hospital, consumer and media data with best-in-class privacy safeguards far exceeding HIPAA requirements. Through an unrivaled commitment to innovation and its first-of-their-kind partnerships, Crossix offers an expansive suite of audience and media optimization solutions across programmatic advertising, addressable TV, mobile marketing, search, Point of Care, and beyond. Founded in 2004, Crossix is headquartered in New York City. For more information, visit www.crossix.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170914005435/en/ |
